Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cloudflare Inc (NET) vs Sana Biotechnology Inc (SANA) Price & Performance

Cloudflare IncTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Cloudflare Inc vs Sana Biotechnology Inc — how do they compare? Cloudflare Inc trades at $307.53 (market cap $109.31B), while Sana Biotechnology Inc trades at $3.79 (market cap $1.13B). The key difference: Cloudflare Inc is far larger — about 96.7× Sana Biotechnology Inc's market cap, and Cloudflare Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

NETSANA
Market Cap
$109.31B$1.13B
Sector
TechnologyHealth
52-Week High
$310.40$5.92
52-Week Low
$160.16$2.68
Enterprise Value
$108.67B$1.05B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cloudflare Inc

Cloudflare (NET) trades at $310.91, up 0.16% with strong technical momentum and bullish moving averages. The company shows robust revenue growth (36% in Q2 2026) and expanding gross margins (72.58%), though it remains unprofitable with a -8.21% net margin. Recent news highlights AI-driven demand and a $2.175 billion convertible note offering, while analyst consensus remains strongly bullish with a $337.10 price target.

The outlook remains positive given strong execution and AI tailwinds, but investors face risks from premium valuation (P/S 42.99), ongoing losses, and competitive pressures. Institutional sentiment is supportive with 72.5% buy ratings, though the stock's proximity to all-time highs warrants caution amid elevated expectations.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.

The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cloudflare Inc

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.

Read more on NET

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA